NCT07283757 PTSD Treatment for Incarcerated Men and Women: AV
| NCT ID | NCT07283757 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | PTSD |
| Study Type | INTERVENTIONAL |
| Enrollment | 900 participants |
| Start Date | 2025-12-22 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 900 participants in total. It began in 2025-12-22 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research will help identify if a PTSD treatment group, called Cognitive Processing Therapy (CPT), that is used in community settings is helpful in reducing PTSD symptoms among people who are incarcerated. The goal of CPT is to create a space for people to modify unhelpful beliefs related to trauma. A total of 692 participants will be enrolled from 6 locations and can expects to be on study for up to 24 weeks.
Eligibility Criteria
Participants will be enrolled from the Department of Corrections trauma treatment waitlist who have been screened for: * No active symptoms of psychosis that would interfere with the individual's ability to participate in the group * No active suicidal ideation with intent or plan * Able and willing to participate in group therapy * 18 years old or older * meet PCL-5 criteria for current PTSD diagnosis within 2 months of enrollment * No scheduled release date before the end of the treatment group * able to understand the consent form as measured by the consent quiz * have not participated in the previous CPT groups with UW project
Contact & Investigator
Michael R Koenigs, PhD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT07283757 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying PTSD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07283757 currently recruiting?
Yes, NCT07283757 is actively recruiting participants. Contact the research team at mrkoenigs@wisc.edu for enrollment information.
Where is the NCT07283757 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT07283757 clinical trial?
NCT07283757 is sponsored by University of Wisconsin, Madison. The principal investigator is Michael R Koenigs, PhD at University of Wisconsin, Madison. The trial plans to enroll 900 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.